Finanzen von Rxsight Inc (RXST)RXSTRxsight Inc

Evaluating the bottom line, RxSight, Inc. maintains a gross margin of 73.62%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -75.32%, while the net margin is -65.99%. These profitability ratios, combined with a Return on Equity (ROE) of -20.10%, provide a clear picture of how effectively RXST converts its operational activities into shareholder value.

In the context of the broader market, RXST competes directly with industry leaders such as SHMD and ESP. With a market capitalization of $209.23M, it holds a leading position in the sector. When comparing efficiency, RXST's gross margin of 73.62% stands against SHMD's 21.24% and ESP's 34.33%. Such benchmarking helps identify whether RxSight, Inc. is trading at a premium or discount relative to its financial performance.

RxSight has reported a gross margin of 76.72% for Q2 2026, but it is facing significant net losses, with a net loss of $12.1 million and an EPS of -0.29 for the same quarter.